Patents
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
09/2008
09/25/2008US20080233119 Modulating death receptor 3 and/or CD30 function; interleukin expression inhibition
09/25/2008US20080233067 Method Of Making Enhanced Efficacy Antiperspirant Actives
09/24/2008EP1601374B1 Compositions and methods for diagnosing and treating an inflammation
09/24/2008EP1035825B2 Hair colorant preparation
09/24/2008CN100420717C Compositions comprising anionic functionalized polyorganosiloxanes for hydrophobically modifying surfaces and enhancing delivery of active agents to surfaces treated therewith
09/23/2008US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease
09/23/2008US7427639 β2-adrenergic receptor agonists
09/23/2008US7427637 Kinesin spindle protein (KSP) inhibitors; antiproliferative and -carcinogenic agents; side effects reduction; used with an estrogen receptor modulator; e.g. bicyclic dihydropyrrole derivatives
09/23/2008US7427629 Immunostimulatory compositions and methods of stimulating an immune response
09/23/2008US7427622 Method of making and using theaflavin, theaflavin-3-gallate, theaflavin-3′-gallate and theaflavin 3,3′-digallate and mixtures thereof
09/23/2008US7427589 Administering substance that inhibits a pro-inflammatory cytokine for prevention or reduction of scar tissue and/or adhesion formation
09/23/2008CA2432872C Pyrazole compounds useful as protein kinase inhibitors
09/23/2008CA2378390C Tixocortol pivalate suspension, collutorium based on it and packaging containing it
09/18/2008US20080228239 Systems And Methods For Altering Vestibular Biology
09/18/2008US20080228069 Novel Differential Imaging Method
09/18/2008US20080227862 histone deacetylase (HDAC) inhibitor useful in selectively inducing terminal differentiation, cell growth arrest and/or apoptosis of neoplastic cells; have a high bioavailability and gives high blood levels of the active compounds over a long time
09/18/2008US20080227810 6-Cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds
09/18/2008US20080227804 Polymorphic solvates of naltrexone with ethanol, benzyl alcohol, dimethylformamide, methanol, dichloromethane, acetone and hexane; sustained release formulations
09/18/2008US20080227778 6-Methoxy-3-(methoxymethyl)-2-methyl-4-phenylisoquinolin-1(2H)-one; treat cardiac arrhythmias
09/18/2008US20080227703 neublastin neurotrophic factor polypeptides for treating neuropathy
09/18/2008US20080227121 Using collagen XIII peptide as evaluative tool in identifying modulators monocyte efflux into interstitial space; treating chronic inflammatory disorders
09/18/2008US20080227114 Compositions and methods for modulating c-rel-dependent cytokine production
09/18/2008US20080226671 Deactivation or attenuation Mycoplasma vaccine for cattle; side effect reduction; respiratory system disorders ; mammary disorders; joint, eye, ear infections
09/18/2008US20080226666 Immunogenic polypeptide for protecting pigs against viral infection or postweaning multisystemic wasting syndrome
09/18/2008US20080226558 Mesoderm and definitive endoderm cell populations
09/17/2008EP1409477B1 Piperidine derivatives as nmda receptor antagonists
09/17/2008CN101265262A New oxabispidine compounds useful in the treatment of cardiac arrhythmias
09/17/2008CN101265226A Compounds and methods for delivery of prostacyclin analogs
09/17/2008CN101264093A Compositions for increasing energy in vivo
09/17/2008CN100418967C Tricyclic inhibitors of poly(ADP-ribose) polymerases
09/17/2008CN100418585C Stable radiopharmaceutical compositions and methods for preparation
09/17/2008CN100418576C Subcutaneously-administered ganglioside-based vaccine compositions
09/17/2008CN100418533C Pharmaceutical combinations of cox-2 inhibitors and opiates
09/17/2008CN100418506C Anti-germ attachment composition
09/16/2008US7425565 Use of benzothiopenes to treat and prevent prostate cancer
09/16/2008US7425547 Nucleoside derivatives for treating hepatitis C virus infection
09/16/2008US7425325 binding ligands and proteins comprising amino acid sequences, having high specificity for the receptor zcytor17, used to induce proinflammatory cytokine production, for stimulating the immune system and proliferation and/or development of hematopoietic cells in vitro and in vivo; antibodies
09/16/2008CA2427221C Process and intermediates for preparing anti-cancer compounds
09/16/2008CA2120732C Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction
09/16/2008CA2110730C Sustained-release preparation
09/12/2008WO2004078116A9 P38 inhibitors and methods of use thereof
09/11/2008US20080221191 Mycobacterium tuberculosis infection; protozoan pathogens; fungal pathogens
09/11/2008US20080221098 Compounds and compositions as protein kinase inhibitors
09/11/2008US20080221065 Pharmaceutical formulations; epothilone and mannitol or a cyclodextrin parenteral administration in the form of an infusion concentrate or lyophilised composition
09/11/2008US20080216606 Grinding to uniform particle size; heating; pressurization;; extraction from ores, concentrates
09/10/2008EP1551417B1 Three layer tear formulation
09/10/2008EP1077691B1 Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same
09/10/2008CN101263143A Crystalline forms of a pyrrolotriazine compound
09/10/2008CN101260152A Method for down-regulating Osteoprotegerin ligand activity
09/10/2008CN100417394C Application of plant extract for preparing medicine to cure bone absorption increment diseases and composition thereof
09/09/2008US7424706 Automatic detection and patching of vulnerable files
09/09/2008US7423123 Interleukin-9 antagonist muteins and their pharmacological methods of use
09/09/2008US7423031 Compounds and compositions as protein kinase inhibitors
09/09/2008US7423013 Protein formulation
09/09/2008US7423004 Provide improved solubility and dissolution, as well as enhanced bioavailability of particulate pharmaceuticals; without the need for using organic solvents and without the need to heat the compound to temperatures above its melting point
09/09/2008CA2304703C Skin-compatible hand cleansers, particularly coarse hand cleansers
09/09/2008CA2287881C Vitamin d3 analogs with bis c-20 side chains
09/09/2008CA2263445C Pharmaceutical aerosol composition
09/04/2008WO2005025489A3 Therapeutic use of g53135-05(fgf-20) in radiation protection
09/04/2008US20080214812 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
09/04/2008US20080214655 Paclitaxel or a paclitaxel analog and 2,5-Dimethoxythiobenzoic acid N-methylhydrazine; antitumor; nontoxic
09/04/2008US20080214640 3'-{[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid or a salt; treatment of thrombocytopenia; may be coadministered with a colony stimulating factor, cytokine, chemokine, or an interleukin or cytokine receptor agonist or antagonist
09/04/2008US20080213351 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
09/04/2008US20080213301 Compositions and methods for healthy pregnancy
09/04/2008US20080213211 Compositions and methods for healthy pregnancy
09/03/2008EP1964921A2 The high bone mass gene of 11q13.3
09/03/2008EP1964850A2 Compositions and methods for the treatment and diagnosis of breast cancer
09/03/2008EP1605862A4 Collagen compositions and biomaterials
09/03/2008CN101257928A Optical imaging contrast agents
09/03/2008CN101255425A OX2 receptor homolog
09/03/2008CN101254302A Treatment of autoimmune diseases with antagonists which bind to b cell surface markers
09/03/2008CN100415737C Indole derivatives useful for treatment of CNS disorders
09/03/2008CN100415735C Amino alcohol derivatives
09/03/2008CN100415222C Methods of using and compositions comprising dopamine reuptake inhibitors
09/03/2008CN100415188C Condom with erectogenic composition
09/02/2008US7420037 Heat shock protein-based vaccines and immunotherapies
09/02/2008US7419964 Treatment of HSV-related pathologies using ssDNA
09/02/2008US7419779 Contacting compound with sumo protease polypeptide; measuring ligand or substrate binding; short interference RNA inhibits gene expression
09/02/2008US7419687 carriers for group IB compounds such as silver nitrate comprising beads made of inert polymers, ceramics or stainless steels, used for treatment of menorrhagia
09/02/2008US7419680 For therapy and prophylaxis of osteoporosis and for bone and fracture repair; slow-releasing, will promote bone formation and inhibit bone resorption
09/02/2008US7419672 Genes and proteins, and their use
09/02/2008US7419653 Method for preparing radiolabeled thymidine having low chromophoric byproducts
09/02/2008CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors
09/02/2008CA2243237C Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application
08/2008
08/28/2008US20080208266 System and Method for Treating Nausea and Vomiting by Vagus Nerve Stimulation
08/28/2008US20080206738 Reduce concentration of nitric oxide ; antiinflamamtory agents, stroke, antiproliferative agents; gastrointestinal disorders; inflammatory bowel disorders; antiarthritic agents; Parkinson's disease; Alzheimer's disease;amyotroic lateral sclerosis; anticancer agents
08/28/2008US20080206335 Inert non-pareil core, fluvoxamine layer over core, rate-controlling membrane coating; fluvoxamine released over a period of 12 hours or more; once-daily oral administration
08/28/2008US20080206269 stimulate the resuscitation of bacteria after true dormancy; cognate receptors, convertases, respective genes and inhibitors or mimetics
08/28/2008US20080206265 Using oligonucleotide immunostimulant mixture with drug; Modification of an immunostimulatory oligonucleotide to optimally present 5' ends dramatically enhances its anti-cancer activity
08/28/2008US20080206219 Using cytokine modulators as therapeutic tools in treatment of vascular permeability disorders
08/28/2008US20080206189 Using water-soluble polymer conjugated interleukin-18 as therapeutic in treatment and prevention of cell proliferative disorders
08/28/2008US20080206141 Optical Imaging Contrast Agents
08/28/2008DE10164893B4 Verfahren zur Herstellung von Artischockenblätterextrakten und so erhaltene Artischockenblätterextrakte Process for the preparation of artichoke leaf extracts and extracts so obtained artichoke leaves
08/27/2008EP1961811A1 Novel cytokine ZCYTOR17 ligand
08/27/2008EP1622569A4 Aza spiro alkane derivatives as inhibitors of metallproteases
08/27/2008EP1210078B1 Improved topical medicaments and methods for photodynamic treatment of disease
08/27/2008CN100413860C Piperidine derivative as NMDA receptor antagonist
08/27/2008CN100413849C Benzimidazole derivatives
08/27/2008CN100413576C Encapsulated essential oils
08/26/2008US7417158 Mycobacterium tuberculosis infection; protozoan pathogens; fungal pathogens
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 295